Dimensional Fund Advisors’s Impax Laboratories, Inc. IPXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-2,688,756
Closed -$52.3M 3416
2018
Q1
$52.3M Sell
2,688,756
-291,242
-10% -$5.72M 0.02% 1295
2017
Q4
$49.6M Sell
2,979,998
-3,966
-0.1% -$72.7K 0.02% 1359
2017
Q3
$60.6M Sell
2,983,964
-260,616
-8% -$4.98M 0.03% 1076
2017
Q2
$52.2M Buy
3,244,580
+607,503
+23% +$8.97M 0.02% 1195
2017
Q1
$33.4M Buy
2,637,077
+845,375
+47% +$10.2M 0.02% 1604
2016
Q4
$23.7M Buy
1,791,702
+194,694
+12% +$3.33M 0.01% 1850
2016
Q3
$37.8M Sell
1,597,008
-40,934
-2% -$1.1M 0.02% 1345
2016
Q2
$47.2M Buy
1,637,942
+85,854
+6% +$2.8M 0.03% 1036
2016
Q1
$49.7M Buy
1,552,088
+56,990
+4% +$2M 0.03% 928
2015
Q4
$63.9M Sell
1,495,098
-9,756
-0.6% -$390K 0.04% 640
2015
Q3
$53M Sell
1,504,854
-81,540
-5% -$3.67M 0.03% 752
2015
Q2
$72.8M Sell
1,586,394
-17,486
-1% -$830K 0.04% 563
2015
Q1
$75.2M Buy
1,603,880
+111,917
+8% +$4.45M 0.05% 510
2014
Q4
$47.3M Buy
1,491,963
+66,259
+5% +$1.94M 0.03% 816
2014
Q3
$33.8M Sell
1,425,704
-4,588
-0.3% -$118K 0.02% 1037
2014
Q2
$42.9M Buy
1,430,292
+48,430
+4% +$1.31M 0.03% 850
2014
Q1
$36.5M Buy
1,381,862
+177,448
+15% +$4.43M 0.03% 926
2013
Q4
$30.3M Buy
1,204,414
+140,967
+13% +$3.14M 0.02% 1051
2013
Q3
$21.8M Buy
1,063,447
+154,806
+17% +$3.2M 0.02% 1319
2013
Q2
$18.1M Buy
+908,641
New +$16.1M 0.02% 1395

Dimensional Fund Advisors's IPXL Position: Q2 2018 in Review

Dimensional Fund Advisors sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 2,688,756 shares — an estimated $52.3M sold.

Dimensional Fund Advisors first reported a position in IPXL in Q2 2013 and held it in 20 quarters. The position peaked at $75.2M in Q1 2015. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

  • Dimensional Fund Advisors reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
  • Dimensional Fund Advisors sold 2,688,756 Impax Laboratories, Inc. shares in Q2 2018, an estimated $52.3M.
  • Dimensional Fund Advisors first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 20 quarters.
  • Dimensional Fund Advisors's Impax Laboratories, Inc. position peaked at $75.2M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Dimensional Fund Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.